Carcinogenesis Advance Access published online on December 12, 2005
Carcinogenesis, doi:10.1093/carcin/bgi311
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Biology, Beckman Research Institute of the City of Hope National Medical Center, 1450 East Duarte Road, Duarte, CA 91010, USA
* To whom correspondence should be addressed. Many genotoxic carcinogens are known to leave unique signatures on cancer-related genes. The signature of carcinogens is manifested by the induction of characteristic mutations at distinctive nucleotide positions along oncogenes and/or tumor suppressor genes. Often, the nucleotide positions, wherein mutations occur, co-localize with the sites of initial DNA damage induced by the respective carcinogens. Thus, DNA damage-targeted mutation can be a predictor of carcinogenicity of genotoxins. Today, genomic sequencing technologies for investigating human cancer etiology are based on DNA-lesion footprinting in conjunction with mutagenicity analysis of genotoxic carcinogens. In this review article, we discuss the ligation-mediated polymerase chain reaction (LM-PCR) and terminal transferase-dependent (TD)-PCR, two versatile DNA-lesion footprinting techniques. We highlight the in vitro shuttle vector-based mutation systems for investigating site-specific mutagenicity of carcinogens and the in vivo transgenic rodent mutation systems for exploring DNA damaging and mutagenic properties of carcinogens. We present examples of application of each of these methodologies to human cancer etiology, and provide prospective views on investigations using these technologies for carcinogenicity testing.
Received October 13, 2005
Revised November 15, 2005
Accepted December 6, 2005
REVIEW
Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis
Ahmad Besaratinia 1 *
and
Gerd P. Pfeifer 1
Ahmad Besaratinia, E-mail: ania{at}coh.org
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J.-H. Yoon, L. Prakash, and S. Prakash Highly error-free role of DNA polymerase {eta} in the replicative bypass of UV-induced pyrimidine dimers in mouse and human cells PNAS, October 27, 2009; 106(43): 18219 - 18224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Besaratinia, S.-i. Kim, and G. P. Pfeifer Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells FASEB J, July 1, 2008; 22(7): 2379 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Kim, G. P. Pfeifer, and A. Besaratinia Lack of Mutagenicity of Acrolein-Induced DNA Adducts in Mouse and Human Cells Cancer Res., December 15, 2007; 67(24): 11640 - 11647. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Arlt, M. Stiborova, J. vom Brocke, M. L. Simoes, G. M. Lord, J. L. Nortier, M. Hollstein, D. H. Phillips, and H. H. Schmeiser Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer Carcinogenesis, November 1, 2007; 28(11): 2253 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Besaratinia and G. P. Pfeifer A review of mechanisms of acrylamide carcinogenicity Carcinogenesis, March 1, 2007; 28(3): 519 - 528. [Abstract] [Full Text] [PDF] |
||||



